Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Blastic plasmacytoid dendritic cell neoplasm following Langerhans cell histiocytosis.

JAAD case reports·2026
Same author

Apremilast for Acrodermatitis Continua of Hallopeau: Report of Two Cases and Review of the Literature.

The Journal of dermatology·2026
Same author

Inducible Costimulator and Its Ligand Promote Proliferation and Migration of Tumor Cells in Cutaneous T-Cell Lymphoma.

International journal of molecular sciences·2026
Same author

Efficacy of venetoclax combined with azacitidine for advanced blastic plasmacytoid dendritic cell neoplasm: experience from two Japanese cases.

Journal of clinical and experimental hematopathology : JCEH·2026
Same author

Mycosis Fungoides Is a Proliferation of Multiple Mutational Subclones.

The Journal of dermatology·2026
Same author

Editorial: HTLV-1 and EBV-related disorders: pathogenesis and clinical advances.

Frontiers in medicine·2025

Related Experiment Video

Updated: Oct 15, 2025

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.1K

Treating Psoriasis with a Light Touch.

Makoto Sugaya1

  • 1Department of Dermatology, Faculty of Medicine, School of Medicine, International University of Health and Welfare, Narita, Japan.

The Journal of Investigative Dermatology
|October 24, 2021
PubMed
Summary
This summary is machine-generated.

Researchers explored a novel strategy for treating psoriasis by targeting an alternative pathway of the interleukin-22 (IL-22) receptor. This approach aims to reduce skin inflammation without compromising gut barrier function.

More Related Videos

Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases
07:36

Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases

Published on: July 3, 2025

279
An In Vitro Approach to Photodynamic Therapy
04:53

An In Vitro Approach to Photodynamic Therapy

Published on: August 17, 2018

8.9K

Related Experiment Videos

Last Updated: Oct 15, 2025

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.1K
Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases
07:36

Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases

Published on: July 3, 2025

279
An In Vitro Approach to Photodynamic Therapy
04:53

An In Vitro Approach to Photodynamic Therapy

Published on: August 17, 2018

8.9K

Area of Science:

  • Immunology
  • Dermatology
  • Inflammation Research

Background:

  • Current psoriasis treatments, including anticytokine therapies, have limitations.
  • There is a need for more effective and better-tolerated psoriasis treatments.

Purpose of the Study:

  • To investigate a novel therapeutic strategy for psoriasis.
  • To target an alternative activation pathway of the IL-22 receptor.
  • To assess the efficacy of this strategy in reducing skin inflammation while preserving gut barrier function.

Main Methods:

  • Utilized a murine model of psoriasis-like skin inflammation.
  • Intervened with a targeted approach to an alternative IL-22 receptor activation pathway.

Main Results:

  • Successfully attenuated murine psoriasis-like skin inflammation.
  • Demonstrated preservation of IL-22-dependent gut barrier defense.

Conclusions:

  • Targeting an alternative IL-22 receptor pathway offers a promising therapeutic strategy for psoriasis.
  • This approach may provide a more targeted treatment with fewer side effects.
  • Further research is warranted to explore clinical applications.